我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

β1整合素反义寡核苷酸抑制精氨酸加压素诱导下心脏成纤维细胞DNA合成的作用

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第6期
页码:
833-837
栏目:
基础研究
出版日期:
2010-08-23

文章信息/Info

Title:
Inhibitory effects of antisense β1 integrin oligodeoxynucleotides on DNA synthesis in cardiac fibroblasts induced by arginine vasopressin
作者:
彭育红1; 赵连友2; 汝磊生1; 杨学东2; 陈永清2 ; 范延红2
1.白求恩国际和平医院心内科,河北 石家庄 050082；2.第四军医大学唐都医院心内科，陕西 西安 710038
Author(s):
PENG Yu-hong1;  ZHAO Lian-you2;  RU Lei-sheng1;  YANG Xue-dong2;  CHEN Yong-qing2;  FAN Yan-hong2
1.Department of Cardiology, Bethune International Peace Hospital, Shijiazhuang 050082, Hebei, China; 2.Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, Shaanxi, China
关键词:
心肌成纤维细胞; 反义寡核苷酸类; 精氨酸升压素DNA合成; SD大鼠
Keywords:
antisense oligodeoxynucleotides;  cardiac fibroblasts;  arginine vasopressin;  β1 integrin
分类号:
R392.12
DOI:
-
文献标识码:
A
摘要:
目的: 探讨β1整合素反义寡核苷酸（ASODN）对精氨酸加压素（AVP）诱导大鼠心脏成纤维细胞（CFs）DNA合成功能的抑制作用。方法: 以胰蛋白酶消化法分离、培养SD大鼠的CFs，采用MTT吸光度法及3H-胸腺嘧啶核苷(3H-TdR)掺入法，原位酶联免疫吸附测定(ELISA)等技术，观察基础状态下β1整合素ASODN对CFs 细胞数目及 DNA合成功能的影响；β1整合素ASODN对AVP诱导的β1整合素表达，CFs增殖及DNA合成功能的影响；基础状态下设空白对照组、反义链组和正义链组；AVP诱导下设空白对照组、1×10-7 mol/L AVP组、反义链＋1×10-7 mol/L AVP组和正义链＋1×10-7 mol/L AVP组，每组均为8个复孔。结果: ①反义链组的CFs细胞数目及3H-TdR掺入率明显低于空白对照组及正义链组，并且均有统计学意义(P<0.01)；正义链组与对照组比较无统计学意义。②1×10-7 mol/L AVP组和正义链＋1×10-7 mol/L AVP组的β1整合素表达水平，CFs细胞数目均高于空白对照组(P<0.05)，β1整合素ASODN与AVP共同作用组的β1整合素表达水平，CFs细胞数目明显低于1×10-7 mol/L AVP组和正义链＋1×10-7 mol/L AVP组，并且均有非常显著性意义(P<0.01)。③1×10-7 mol/L AVP组和正义链＋1×10-7 mol/L AVP组的CFs 3H-TdR掺入率均高于空白对照组(P<0.05)，β1整合素ASODN与AVP共同作用组的CFs 3H-TdR掺入率明显低于空白对照组、1×10-7 mol/L AVP组和正义链＋1×10-7 mol/L AVP组，并且均有非常显著性意义(P<0.01)。结论: β1整合素ASODN不但抑制基础状态下CFs 生长及DNA合成代谢，而且抑制AVP刺激β1整合素表达、CFs增殖、DNA合成的作用，说明针对特异性靶基因片段合成的ASODN可能抑制β1整合素遗传信息传递的某个环节，干扰细胞内外信息的传递，影响β1整合素介导的CFs与细胞外基质的黏附，从而产生拮抗AVP刺激心脏间质重构形成的作用。进一步提示应用反义药物防治高血压心脏间质重构的可能性。
Abstract:
AIM: To explore the effects of β1 integrin antisense oligodeoxynucleotides (ASODN) on the DNA synthesis in cardiac fibroblasts (CFs) induced by arginine vasopressin (AVP). METHODS: CFs of Sprague Dawley neonatal rats were separated and cultured using trypsin. MTT techniques and enzyme-linked immunosorbent assay (ELISA) were adopted to evaluate the number and expression of β1 integrin in CFs. DNA synthesis was measured by incorporation of 3H-thymidine (3H-TdR) in blank control group (n=8), β1 integrin sense oligodeoxynucleotide group (n=8) and β1 integrin ASODN group (n=8). The effects of β1 integrin ASODN on the DNA synthesis in CFs pretreated with AVP were also observed. RESULTS: The number of CFs cultured and the 3H-TdR incorporation value in CFs by ASODN were significantly lower than in control and sense group (P<0.01). In the group pretreated with 1×10-7 mol/L AVP and group of sense+1×10-7 mol/L AVP, the expression of β1 integrin in CFs and the number of CFs were significantly higher than in control (P<0.05), whereas in the group of added ASODN+1×10-7 mol/L AVP, the expression of 1 integrin and the number of CFs was significantly lower than in 1×10-7 mol/L AVP group and sense oligos+1×10-7 mol/L AVP group (P<0.01). In the group pretreated with 1×10-7 mol/L AVP and group of sense+1×10-7 mol/L AVP, the 3H-TdR incorporation value in CFs was significantly higher than in control (P<0.05), whereas the 3H-TdR incorporation value in CFs with added ASODN+1×10-7 mol/L AVP was significantly lower than in blank control group, 1×10-7 mol/L AVP group and sense oligos+1×10-7 mol/L AVP group (P<0.01). CONCLUSION: CF proliferation and DNA synthesis can be effectively inhibited by β1 integrin ASODN. The effects of AVP on the expression of β1 integrin in CFs, CF proliferation and DNA synthesis can also be effectively inhibited by ASODN, but they are not weakened by sense oligodeoxynucleotides, indicating that restraining of a gene segment would limit one of the steps of information transduction on expression of integrin, inhibit the transduction of cell information, interfere with the inhesion of ECM and CFs, and then reverse cardiac remodeling by AVP. β1 integrin ASODN may be a new drug for modulating interstitial remodeling in essential hypertensive patients.

参考文献/References

［1］Krishnamurthy P, Subramanian V, Singh M, et al. Beta 1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling［J］. Hypertension, 2007, 49(4):865-872.

［2］赵连友，彭育红，陈永清,等. 反义寡核苷酸对精氨酸升压素诱导心脏成纤维细胞β1整合素表达的抑制作用［J］. 中华心血管病杂志, 2003, 31(7):523-527.

［3］彭育红，赵连友，陈永清，等. 反义β1整合素寡核苷酸对精氨酸加压素促胶原凝胶收缩的抑制作用［J］. 心脏杂志, 2001, 13(2):112-114.

［4］Malek-Hedayat S, Rome LH. Cloning and sequence of the cDNA encoding the rat oligodendrocyte integrin beta 1 subunit［J］. Gene, 1995, 158(2):287-290.

［5］ Mitsuhashi M. Strategy for designing specific antisense oligonucleotide sequences［J］. J Gastroenterol, 1997, 32(2):282-277.

［6］司徒镇强，吴军正. 细胞培养［M］. 西安: 世界图书出版公司, 1996:186-187.

[7] 陈萍. 放射性同位素技术［M］. 陕西: 陕西科学技术出版社, 199:44-92.

[8] Weber KT, Janicki JS, Pick R, et al. Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension［J］. Am J Cardiol, 1990, 65(14): 1G-7G.

[9] Adelsman MA, McCarthy JB, ShimizuY, et al. Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase［J］. Mol Biol Cell, 1999, 10(9):2861-2878.

[10]Meredith JE Jr, Winitz S, Lewis JM, et al. The regulation of growth and intracellular signaling by integrins［J］. Endocr Rev, 1996, 17(3):207-220.

［11]Hannigan GE, Dedhar S. Protein kinase mediators of integrin signal transduction［J］. J Mol Med, 1997, 75(1):35-44.

[12]赵连友,曹世平.高血压患者血浆精氨酸加压素浓度的变化及其与病情的关系［J］. 中华心血管病杂志, 1993, 21(3):147-149.

[13]Beltinger C, Saragovi HU, Smith RM, et al. Binding, uptake, and intracellular trafficking of phosphorothioate modified oligodeoxynucleotides［J］. J Clin Invest, 1995, 95(4):1814-1823.

[14]查锡良. 细胞粘附分子［M］.上海: 上海医科大学出版社，1998:123-142.

[15] Hiroyama M, Wang SY, Aoyagi T, et al. Vassopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonata 1 mice［J］. Eur J Pharmacol, 2007, 559(2):89-97.

备注/Memo

备注/Memo:
收稿日期：2009-09-15.通讯作者：赵连友，主任医师，主要从事冠心病及高血压病基础与临床研究Email:zhaoly.fmmu@yahoo.com.cn 作者简介：彭育红，主治医师，硕士Email：pyh1a@Yahoo.com.cn
更新日期/Last Update: 2010-08-22